title: Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma.
authors.forename: Deivasikamani
authors.initials: D
authors.lastname: Ramanujam
authors.forename: Feargal
authors.initials: F
authors.lastname: McNicholl
authors.forename: Darshayani
authors.initials: D
authors.lastname: Furby
authors.forename: Deborah
authors.initials: D
authors.lastname: Richardson
authors.forename: Robert J G
authors.initials: RJ
authors.lastname: Cuthbert
authors.forename: Mary F
authors.initials: MF
authors.lastname: McMullin
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001250:Asthma, Exercise-Induced / Q000175:diagnosis*; D001402:B-Lymphocytes / Q000378:metabolism; D001549:Benzamides; D003371:Cough / Q000188:drug therapy / Q000209:etiology; D003951:Diagnostic Errors; D004417:Dyspnea / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D015444:Exercise; D006801:Humans; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D017997:Leukotriene C4 / Q000378:metabolism; D008297:Male; D010257:Paraneoplastic Syndromes / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D017997:Leukotriene C4; D000068877:Imatinib Mesylate